跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8 条关于
“PAPZIMEOS”
全部
8
临床试验
0
药物
0
机构
0
资讯
8
去年
Precigen Secures $125 Million Credit Facility to Advance PAPZIMEOS Commercialization
去年
Precigen's Papzimeos Becomes First FDA-Approved Treatment for Rare Respiratory Disease
7年前
Precigen Receives FDA Approval for Papzimeos, First Treatment for Recurrent Respiratory Papillomatosis
去年
FDA Approves Precigen's PAPZIMEOS as First Gene Therapy for Recurrent Respiratory Papillomatosis
2个月前
Precigen CFO Sells $1.1 Million in Shares Amid Stock Surge and FDA Orphan Drug Designation for Papzimeos
6个月前
FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis, Offering Hope for Rare Voice-Threatening Disease
去年
FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis
上个月
PM360 Names Alex Gorsky Lifetime Achievement Honoree and Lina Polimeni CMO of the Year for 2026 Trailblazer Awards